References
- From NORDCAN. Nordcan is a database with information and data regarding incidence, mortality rates, prevalence and survival rates for 41 cancers in the nordic countries (www.dep.iarc.fr/NORDCAN/DK/frame.asp).
- Afzelius P, Zedeler K, Sommer H, Mouridsen HT, Blichert-Toft M. Patient's and doctor's delay in primary breast cancer. Prognostic implications. Acta Oncol 1994;33:345–51.
- Kaufman M, Hortobagyi GN, Goldhirsch A, Scholl S, Makris A, Valagussa P, . Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update. J Clin Oncol 2006;24:1940–9.
- Caplan L, Helzlsouer K. Delay in breast cancer: A review of the literature. Public Health Rev 1992–1993;20:187–214.
- Nosarti C, Crayford T, Roberts JV, Elias E, McKenzie K, David AS. Delay in presentation of symptomatic referrals to a breast clinic: Patient and system factors. Br J Cancer 2000;82:742–8.
- Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 1999;353:1119–26.
- Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H. Patient delay and stage of diagnosis among breast cancer patients in Germany – a population based study. Br J Cancer 2002;86:1034–40.
- Burgess C, Hunter MS, Ramirez AJ. A qualitative study of delay among women reporting symptoms of breast cancer. Br J Gen Pract 2001;51:967–71.
- Andersen KW, Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 1988;27:627–47.
- Carlsen K, Høybye MT, Dalton SO, Tjønneland A. Social inequality and incidence of and survival from breast cancer in a population-based study in Denmark, 1994–2003. Eur J Cancer 2008;44:1996–2002.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987;40:373–83.
- Bushe CJ, Bradley AJ, Wildgust HJ, Hodgson RE. Schizophrenia and breast cancer incidence – A systematic review of clinical studies. Schizophr Res 2009;114:6–16.
- Meechan G, Collins J, Petrie KJ. The relationship of symptoms and psychological factors to delay in seeking medical care for breast symptoms. Prev Med 2003;36:374–8.
- Meechan G, Collins J, Petrie K. Delay in seeking medical care for self-detected breast symptoms in New Zealand women. N Z Med J 2002;115:U257.
- Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389–99.
- Pack GT, Gallo JS. The culpability for delay in the treatment of cancer. Am J Cancer 1938;33:443–62.
- Adam SA, Horner JK, Vessey MP. Delay in treatment for breast cancer. Community Med 1980;2:195–201.
- Gould J, Fitzgerald B, Fergus K, Clemons M, Baig F. Why women delay seeking assistance for locally advanced breast cancer. Can Oncol Nurs J 2010;20:23–9.
- From DBCG. In the DBCG register it is recorded if the patient suffers from dementia or other diseases.
- Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, . Breast cancer factors associated with stage at diagnosis in black and white women. J Natl Cancer Inst 1993;85:1129–37.
- Coates R, Bransfield D, Wesley M, Hankey B, Eley JW, Greenberg RS, . Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. J Natl Cancer Inst 1992;84:938–50.
- Zaloznik AJ. Breast cancer stage at diagnosis: Caucasians versus Afro-Americans. Breast Cancer Res Treat 1995;34:195–9.
- Weinman S, Taplin SH, Gilbert J, Beverly RK, Geiger AM, Yood MU, . Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. J Natl Cancer Inst Monogr 2005;35:33–8.
- Mohamed IE, Skeel WK, Tamburrino M, Wryobeck J, Carter S. Understanding locally advanced breast cancer: What influences a woman's decision to delay treatment? Prev Med 2005;41:399–405.